Top Trends in Healthcare and OTC 2017: Exploring OTC medication, vitamins, minerals and supplements; functional food and drink; and sports nutrition categories

2017-05-05
Price :
Published : May-2017
No. of Pages : 44

Global consumers are becoming more health-conscious as a reaction to rising obesity levels and lifestyle-related illnesses, such as diabetes, in the modern world. Consumers’ busy lives are a major driver for the healthcare and OTC market as people opt for more convenient, multifunctional, and personalized products that better target their specific needs.

Over-the-counter (OTC) drugs are those sold directly to a consumer without a prescription from a healthcare professional, as compared to prescription drugs, which may be sold only to consumers possessing a valid prescription.

The pressures of modern life are taking their toll on consumers as their increasingly hectic lifestyles, due to work, active social lives and family responsibilities, means that stress is the most concerning health issue globally. As a result, healthcare products that help people become either more energized or focused (at work), or more relaxed (outside of work), will be very appealing to stressed consumers.

The majority of global consumers, 62%, are influenced by how a products health and wellbeing when choosing food products; while 60% are influenced when choosing non-alcoholic drinks.1 This is mainly the result of consumers greater awareness about the importance of a healthy balanced diet to their overall wellbeing. The importance of health and wellness for food and drink products is also due to the high levels of obesity impacting global consumers, particularly in more developed nations, causing concern amongst many individuals.

It has identified following key trends in healthcare and OTC –

  • Multifunctional Products: Time poor consumers increasingly demand more multifunctional medicine, food and drink to effectively combat different symptoms simultaneously.
  • Tailor-Made For Me: Consumers are realizing one size doesn’t always fit all, creating demand for more personalized products that target specific ages, gender, DNA, and usage occasions.
  • Natural Lifestyles: Growing distrust of ¬Ďartificial’ ingredients means consumers are going ¬Ďback to basics’ and seeking more natural healthcare products that promote an all-encompassing holistic lifestyle.
  • Smart Healthcare: Smartphones are set to revolutionize the ways in which consumers monitor their health as people increasingly turn to apps and the “internet of things.”

The report “Top Trends in Healthcare and OTC 2017”, covers key trends to watch within the healthcare and over-the-counter sector, insight analysis, innovation intelligence, and product examples. Moreover, this report helps to understand which audiences are most affected by these trends, learn what the key opportunities, drivers, and inhibitors of the top trends are.

Companies mentioned in this report: Cold-Eeze, UVO, Culturelle, Kuxtal Alimentos Funcionales, Berocca Performance, Dr. Jacob’s, Optrex Night Restore, Thylbert, Vive Organic, Masumax, Nature’s Jeannie.

Scope

  • 66% of global consumers agree that they are more likely to purchase products developed for their lifestyles.
  • 77% of global consumers believe that “natural” claims are nutritious.
  • 19% of global consumers will usually turn first to the internet for health or medical advice compared to 43% who first go to doctors or medical professionals.

Reasons to buy

  • Understand what the top trends are in the healthcare and OTC market.
  • Understand which audiences are most affected by these trends.
  • Learn what the key opportunities, drivers, and inhibitors of the top trends are.
  • See the actions that major brands are taking to get ahead.
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Company Profile: 23andMe

Company Profile: 23andMe Summary 23andMe is a personal genomics and biotechnology company that leverages machine learning technology to provide DNA analysis services. It also offers web-based interactive tools to individuals, helping them understand their own genetics information. Scope The report provides information and insights into 23andMe, including - - Overview of the company and its product offering - Detailed insight into its business operation, technology, revenue model, geographical presence and business model - Information on partnerships, funding and awards it received - Biography of top management. Reasons to buy - Gain insights into 23andMe's business operations. - Gain insights into funding and partnerships. - Gain understanding about its technology focus and success ......
$350

Company Profile: Fitbit, Inc.

Company Profile: Fitbit, Inc. Summary Fitbit, Inc. (Fitbit) offers a range of connected health and fitness devices that monitors various health parameters like sleep duration, heart rate, BMI, calories burned, exercise routines, etc. Scope The report provides information and insights into Fitbit, Inc., including - - Overview of the company and its product offering - Detailed insight into its business operation, technology, revenue model, geographical presence and business model - Information on partnerships, funding and awards it received - Biography of top management. Reasons to buy - Gain insights into Fitbit business operations. - Gain insights into funding and partnerships. - Gain understanding about its technology focus and success factors.......
$350

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in India. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of India. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by ......
$1995

The State of the Microbiome

The State of the Microbiome Summary GlobalData's "The State of the Microbiome", report provides an assessment of how the pharmaceutical industry perceives the state of the microbiome, including the challenges associated with developing, launching, and manufacturing microbiome therapeutics as well as where opportunity remains to invest in the microbiome space. Scope - Microbiome investment - determine level of activity and investment in the development of microbiome therapeutics by therapy area - Identify the challenges associated with - Developing microbiome therapeutics - Launching microbiome therapeutics - Manufacturing microbiome therapeutics. Reasons to buy - Develop and design your corporate strategies in the microbiome space by understanding the challenges associated with devel......
$1495

Rheumatoid Arthritis: Epidemiology Forecast to 2027

Rheumatoid Arthritis: Epidemiology Forecast to 2027 Summary Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the body's immune system attacks the lining of the joints, known as the synovial membrane, or synovium, causing an inflammatory response. The disease can lead to premature mortality, disability, and decreased quality of life. GlobalData epidemiologists used sources that provided the diagnosed incidence, diagnosed prevalence, and total prevalence of RA based on the 1987 American College of Rheumatology (ACR) criteria and International Classification of Diseases, Tenth Edition (ICD-10): M05 and M06. In 2......
$3995

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q3 2018

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2018 Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2018", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q3 2018. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides informati......
$1500

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of China. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by ......
$1995

Cardiometabolic Disease Global Clinical Trials Review, H2, 2018

Cardiometabolic Disease Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Cardiometabolic Disease Global Clinical Trials Review, H2, 2018" provides an overview of Cardiometabolic Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Cardiometabolic Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma e......
$2500

Chondrosarcoma Global Clinical Trials Review, H2, 2018

Chondrosarcoma Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Chondrosarcoma Global Clinical Trials Review, H2, 2018" provides an overview of Chondrosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Chondrosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clin......
$2500

Cervical Cancer Global Clinical Trials Review, H2, 2018

Cervical Cancer Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Cervical Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy